Cargando…
Investigational drugs for the treatment of AD: what can we learn from negative trials?
Given the level of interest and activity in the race to find a treatment for Alzheimer's disease, it is expected that a reasonably safe and effective drug will be identified within the next decade. It may be worthwhile to pause periodically during the course of this race to take stock of what w...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226276/ https://www.ncbi.nlm.nih.gov/pubmed/21539725 http://dx.doi.org/10.1186/alzrt73 |